Back to results

Dominican University of California

Preclinical Evaluation of Matrix Metalloproteinase Inhibitors and Protein Kinase C Activators in Cell and Mouse Models of Huntington’s Disease

Abstract

dc:description.abstract

<p>Huntington’s disease (HD) is an incurable genetic neurological disorder that affects 1 in 10,000 people, with no treatment that can alter the course of the disease. Neural cell death in the striatum and the cortex results from the accumulation of toxic mutant huntingtin protein (mHTT) fragments. Full length HTT is cleaved by proteases, including caspases, calpains and matrix metalloproteinases (MMPs). Previous research has also shown altered kinase signaling pathways in HD contribute to the localization of mutant huntingtin to the nucleus and to disruption of transcriptional regulation. Currently, there are no drugs that delay the onset or slow the progression of Huntington’s disease. We hypothesized that known drugs that target specific enzymes that have been evaluated in cancers and other neurological diseases may have therapeutic benefit in HD. Such enzymes that have been evaluated are MMP inhibitors and PCK activators, both enzymes that have been known to impact proteolytic processing and localization of mutant huntingtin. We evaluated these previously established compounds and their effect in HD mouse striatal cells, human neural stem cells, and transgenic mouse models. We have evaluated three MMP inhibitor compounds and found one that crosses the blood brain barrier and as predicted inhibits gelatinases. We have also found the PKC activator, Bryostain-1, increased the average life span in HD R6/2 treated mice.</p>

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Master's Thesis
Discipline thesis:degree_discipline
Biological Sciences
Year dc:date.available
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Madushani, Kuruwitage
Contributors dc:contributor
  • Lisa M. Ellerby, PhD
  • Robert Barr, PhD
  • Meredith Protas, PhD

Subjects

dc:subject × 9

Identifiers

dc:identifier.*
Repository record dc:identifier
https://scholar.dominican.edu/masters-theses/333
OAI identifier oai:identifier
oai:scholar.dominican.edu:masters-theses-1353

Chain of custody

source
Harvested from
Dominican University of California
Base URL
scholar.dominican.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Madushani, Kuruwitage. Preclinical Evaluation of Matrix Metalloproteinase Inhibitors and Protein Kinase C Activators in Cell and Mouse Models of Huntington’s Disease. Master's Thesis thesis, 2018. https://scholar.dominican.edu/masters-theses/333